Ignite Creation Date:
2024-05-06 @ 1:20 PM
Last Modification Date:
2024-10-26 @ 1:12 PM
Study NCT ID:
NCT03991403
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-04-03
First Post:
2019-06-05
Brief Title:
Study of Atezolizumab Combination Carboplatin Paclitaxel Bevacizumab in EGRF Mutation or ALK Translocation NSCLC
Sponsor:
Samsung Medical Center
Organization:
Samsung Medical Center
Organization Data
Organization:
Samsung Medical Center
Class:
OTHER
Study ID:
2019-03-027
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Samsung Medical Center
Lead Sponsor Class:
OTHER
Responsible Party:
Myung-Ju Ahn
Responsible Party Title:
MD Professor Division of Hematology-Oncology Department of Medicine
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Samsung Medical Center
Old Name:
None
Old Organization:
None